IR Department
  • About Us
    • Overview
    • Our Team
    • Our ESG Position
    • Careers
  • Services
    • What We Do
    • Investor Relations
    • IPO Readiness
    • Media Relations
    • Issues and Crisis Communications
    • Digital Content & Social Media Activation
    • Marketing and Brand Campaigns
    • Video Production
    • ESG
    • ESG Competent Boards Masterclass
  • News & events
    • Blog
  • Contact
    • Contact Us
    • Email Alerts
IR Department Newsletter - March 2022
News & events >
  • Blog

Recent Posts

  • HealthInvest September 2025
  • Inside the Deal Room: Expert Insights from Biotech Leaders
  • Meet our newest team member: Azal Khan
  • HealthInvest April 2025 recap: bringing life sciences to the forefront
  • Upcoming: HealthInvest April 2025

Archives

  • September 2025
  • August 2025
  • April 2025
  • March 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • May 2024
  • December 2023
  • October 2023
  • July 2023
  • March 2023
  • February 2023
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022

Categories

  • AGMs
  • Crisis communications
  • Equity Insights
  • ESG
  • Investor relations
  • Newsletter March 2022
  • Newsletter Sept 2022
  • Uncategorized

Inside the Deal Room: Expert Insights from Biotech Leaders

Posted on August 26th, 2025 . Updated on September 9th, 2025 by Azal Khan

At the recent 19th Bioshares Biotech Summit, four seasoned executives participated in a panel discussion pulling back the curtain on what it really takes to strike, manage, and close successful biotech deals. IR Department’s Managing Director Jane Lowe and Communications Director Cherie Hartley co-authored an article for Bioshares capturing the insights of some of the sector’s most experienced dealmakers.

The feature, Inside the Deal Room: Expert Advice from Biotech’s Top Dealmakers, draws on candid perspectives from:

  • Dr Nina Webster, CEO of Dimerix
  • Wayne Paterson, CEO of Anteris Technologies Global Corporation
  • Brent Barnes, CEO of Clever Culture Systems
  • Anthony Filippis, CEO of Neurotech International

From running a competitive and controlled process, to the risks of partnering under duress, their advice offered a rare behind-the-scenes look at the art and realities of dealmaking.

For companies in the biotech space, the message was clear: effective and thoughtful dealmaking is built on relationships, readiness, and realism.

Read the full article in Bioshares here.

Posted in Uncategorized

IR Department acknowledge the Traditional Owners of the land on which it operates and pays respect to Elders past, present and emerging.

Subscribe

Which of the following group do you best fit?

 
By subscribing you agree to with our Privacy Policy

Site Map Privacy Search
IR Department . All rights reserved. - Site by